Ensysce corrects scrivener's error in Series B Preferred Stock designation

Ensysce Biosciences, Inc.

Filed Certificate of Correction on March 18, 2026 to fix a scrivener's error in the Series B Preferred Stock designation.
Correction is to the Certificate of Designation, which is part of the Certificate of Incorporation.
No change in the rights or terms of the Series B Preferred Stock as a result of the correction.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Ensysce Biosciences, Inc.: Filed Certificate of Correction to Certificate of Designation of Series B Preferred Stock to correct a scrivener's error (effective 2026-03-18).

Change: charter amendment
Effective: 2026-03-18

Exact text from the filing

On March 18, 2026, Ensysce Biosciences Inc. (the “Company”) filed with the State of Delaware a Certificate of Correction (the “ CoC ”) to our Certificate of Designation of Series B Preferred Stock, which Certificate of Designation is part of our Certificate of Incorporation. The CoC corrects a scrivener’s error as set forth in the full text of the CoC attached hereto as Exhibit 3.1 and that text is incorporated herein by reference.

View on SEC.gov

42 governance changes filed in the last 30 days. Browse all governance changes →

Ensysce Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-012062

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.